Press Room

Villax Family at B Corp Summer Summit 2017

Start
Tuesday, June 20, 2017 - 17:30
End
Thursday, June 22, 2017 - 18:00
Location: Cascais, Portugal
B Corp Summer Summit 2017 | Hovione

At the B Corp Summer Summit in Cascais, 22nd June 2017, Marcello Palazzi, Co-Founder & Board Member of B Lab Europe, will be interviewing the 3 generations of the Villax Family.

Diane Villax (founder chairman), Sofia Villax (board member) and Carolina Villax (member of the Family Assembly) will share the history, the present and the future of Hovione and how Hovione’s values overlap with those of B Corp movement.

 

Find more about B Corporation

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025